Sulfonamide compounds, also known as sulfa drugs, are a significant class of synthetic
bacteriostatic antimicrobials and were the primary source of therapy against bacterial …

Ninety years after the discovery of the virus causing the influenza disease, this malady
remains one of the biggest public health threats to mankind. Currently available drugs and …

In silico modelling studies were executed on thirty two N-substituted oseltamivir derivatives
as inhibitors of influenza virus H5N1. Robust validated quantitative structure–activity …

Background This research provides a comprehensive analysis of QSAR modeling
performed on 25 aryl sulfonamide derivatives to predict their effective concentration (EC 50) …

Influenza A viruses possess a high antigenic shift, and the approved anti-influenza drugs are
extremely limited, which makes the development of novel anti-influenza drugs for the clinical …

Sinuscalide A (1), featuring an uncommon 8/8-fused carbon scaffold, three new
norditerpenes, sinuscalides B–D (2–4), and sinuscatone A (5), with a 5/4/9 tricyclic carbon …

Abstract Enterovirus 71 (EV-A71) infection causes severe hand-foot-and-mouth disease that
leads to cardiopulmonary complications and death in young children under 5 years of age …

This study was done to report virtual screening and molecular docking studies of
sulfacetamide derivatives as new antimicrobial drugs, belonging to the pharmacological …

Influenza viruses (IV) cause substantial morbidity and mortality through routine seasonal
spread and epidemics. A novel series of butenolides were discovered to be able to inhibit …

Currently, entry inhibitors contribute immensely in developing a new generation of anti-
influenza virus drugs. Our earlier studies have identified that 3-O-β-chacotriosyl ursolic acid …